Pulmonary embolism (PE) is a common disease with an annual incidence rate ranging from
39–115 per 100,000 inhabitants. It is one of the leading causes of cardiovascular mortality in …

Massive pulmonary embolism (MPE) carries significant 30-day mortality and is characterized
by acute right ventricular failure, hypotension, and hypoxia, leading to cardiovascular …

Thanks to advances in interventional cardiology technologies, catheter-directed treatment
has become recently a viable therapeutic option in the treatment of patients with acute …

Acute pulmonary embolism (PE) is a leading cause of modern cardiovascular morbidity and
mortality. While both acute PE and acute coronary syndrome (ACS) both reflect arterial …

Three types of surgery can be performed for pulmonary emboli depending on the extent and
degree of organization of the thrombi (pulmonary embolectomy, pulmonary thrombo …

Pulmonary embolism (PE) is the third leading cause of cardiovascular mortality. The
management of PE is currently evolving given the development of new technologies and …

Background High-risk pulmonary embolism (PE) is a complex, life-threatening condition,
and emergency clinicians must be ready to resuscitate and rapidly pursue primary …

Background Massive or high‐risk pulmonary embolism (PE) is a potentially life‐threatening
diagnosis with significant morbidity and mortality if treatment is delayed. Extracorporeal …

Patients with PE-related cardiac arrest (PERCA) are at elevated risk of mortality, and merit
urgent, definitive pharmacologic and mechanical interventions to remove pulmonary arterial …

High-risk pulmonary embolism (PE) refers to a large embolic burden causing right
ventricular failure and hemodynamic instability. It accounts for approximately 5% of all cases …